Patents by Inventor Daniel Gelbart
Daniel Gelbart has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12201397Abstract: The invention may be applied to selectively heat a diseased area in the lung while minimizing heating to the healthy area and surrounding tissue. This can be done by exposing the lung to an electromagnetic field causing dielectric or eddy current heating. The invention is particularly useful for treating emphysema as the diseased areas in emphysema patients have reduced blood flow. The diseased area will heat up rapidly while the healthy tissue will be cooled by the blood flow. This is particularly effective for treating emphysema because of the low mass of the lungs and the high blood flow. To avoid heating of surrounding organs the direction of the electromagnetic energy may be switched in a way it always passes through lungs but only intermittently passes through adjacent organs.Type: GrantFiled: August 23, 2022Date of Patent: January 21, 2025Assignee: IKOMED Technologies Inc.Inventors: Samuel Victor Lichtenstein, Daniel Gelbart, Eran Elizur, Kevin James Cannons
-
Publication number: 20240125402Abstract: A throttle valve creates the equivalent of a small orifice by using a much larger orifice which is turned on and off periodically, creating a flow equivalent to a much smaller orifice. The ratio of on time to off time is changed to create the desired effective orifice. By using an elastomeric member to form the orifice seal, solid particles do not interfere with the operation of the valve.Type: ApplicationFiled: October 15, 2022Publication date: April 18, 2024Inventor: Daniel Gelbart
-
Patent number: 11801091Abstract: A device positionable in a cavity of a bodily organ (e.g., a heart) may discriminate between fluid (e.g., blood) and non-fluid tissue (e.g., wall of heart) to provide information or a mapping indicative of a position and/or orientation of the device in the cavity. Discrimination may be based on flow, or some other characteristic, for example electrical permittivity or force. The device may selectively ablate portions of the non-fluid tissue based on the information or mapping. The device may detect characteristics (e.g., electrical potentials) indicative of whether ablation was successful. The device may include a plurality of transducers, intravascularly guided in an unexpanded configuration and positioned proximate the non-fluid tissue in an expanded configuration. Expansion mechanism may include helical member(s) or inflatable member(s).Type: GrantFiled: October 16, 2020Date of Patent: October 31, 2023Assignee: KARDIUM INC.Inventors: Daniel Gelbart, Douglas Wayne Goertzen, Fernando Luis de Souza Lopes
-
Patent number: 11751940Abstract: A device positionable in a cavity of a bodily organ (e.g., a heart) may discriminate between fluid (e.g., blood) and non-fluid tissue (e.g., wall of heart) to provide information or a mapping indicative of a position and/or orientation of the device in the cavity. Discrimination may be based on flow, or some other characteristic, for example electrical permittivity or force. The device may selectively ablate portions of the non-fluid tissue based on the information or mapping. The device may detect characteristics (e.g., electrical potentials) indicative of whether ablation was successful. The device may include a plurality of transducers, intravascularly guided in an unexpanded configuration and positioned proximate the non-fluid tissue in an expanded configuration. Expansion mechanism may include helical member(s) or inflatable member(s).Type: GrantFiled: August 17, 2020Date of Patent: September 12, 2023Assignee: KARDIUM INC.Inventors: Daniel Gelbart, Douglas Wayne Goertzen, Fernando Luis de Souza Lopes
-
Publication number: 20230158319Abstract: The present technology may be applied to selectively heat one or more diseased areas in the lung while limiting heating to the healthy area and surrounding tissue. This heating provides a therapeutic effect. The selective heating of diseased tissues may be achieved by exposing the lung to an electromagnetic field to cause dielectric or eddy current heating. The present technology is particularly useful for treating emphysema as the diseased areas in emphysema patients have reduced blood flow. The diseased areas will heat up rapidly while the healthy tissue will be cooled by blood flow. This is particularly effective for treating emphysema because of the low mass of the lungs and the high blood flow. In one described embodiment the frequency of the electromagnetic radiation is selected to satisfy certain resonance conditions of the apparatus.Type: ApplicationFiled: November 25, 2022Publication date: May 25, 2023Inventors: Kar-Pan WONG, Eran ELIZUR, Evan GOODACRE, Susanna Kim WOLFF, Daniel GELBART
-
Patent number: 11633231Abstract: A device positionable in a cavity of a bodily organ (e.g., a heart) may discriminate between fluid (e.g., blood) and non-fluid tissue (e.g., wall of heart) to provide information or a mapping indicative of a position and/or orientation of the device in the cavity. Discrimination may be based on flow, or some other characteristic, for example electrical permittivity or force. The device may selectively ablate portions of the non-fluid tissue based on the information or mapping. The device may detect characteristics (e.g., electrical potentials) indicative of whether ablation was successful. The device may include a plurality of transducers, intravascularly guided in an unexpanded configuration and positioned proximate the non-fluid tissue in an expanded configuration. Expansion mechanism may include helical member(s) or inflatable member(s).Type: GrantFiled: August 17, 2020Date of Patent: April 25, 2023Assignee: KARDIUM INC.Inventors: Daniel Gelbart, Douglas Wayne Goertzen, Fernando Luis de Souza Lopes
-
Publication number: 20220400953Abstract: The invention may be applied to selectively heat a diseased area in the lung while minimizing heating to the healthy area and surrounding tissue. This can be done by exposing the lung to an electromagnetic field causing dielectric or eddy current heating. The invention is particularly useful for treating emphysema as the diseased areas in emphysema patients have reduced blood flow. The diseased area will heat up rapidly while the healthy tissue will be cooled by the blood flow. This is particularly effective for treating emphysema because of the low mass of the lungs and the high blood flow. To avoid heating of surrounding organs the direction of the electromagnetic energy may be switched in a way it always passes through lungs but only intermittently passes through adjacent organs.Type: ApplicationFiled: August 23, 2022Publication date: December 22, 2022Inventors: Samuel Victor LICHTENSTEIN, Daniel GELBART, Eran ELIZUR, Kevin James CANNONS
-
Patent number: 11445911Abstract: The invention may be applied to selectively heat a diseased area in the lung while minimizing heating to the healthy area and surrounding tissue. This can be done by exposing the lung to an electromagnetic field causing dielectric or eddy current heating. The invention is particularly useful for treating emphysema as the diseased areas in emphysema patients have reduced blood flow. The diseased area will heat up rapidly while the healthy tissue will be cooled by the blood flow. This is particularly effective for treating emphysema because of the low mass of the lungs and the high blood flow. To avoid heating of surrounding organs the direction of the electromagnetic energy may be switched in a way it always passes through lungs but only intermittently passes through adjacent organs.Type: GrantFiled: May 25, 2017Date of Patent: September 20, 2022Assignee: Ikomed Technologies Inc.Inventors: Samuel Victor Lichtenstein, Daniel Gelbart, Eran Elizur, Kevin James Cannons
-
Patent number: 11432874Abstract: A device positionable in a cavity of a bodily organ (e.g., a heart) may discriminate between fluid (e.g., blood) and non-fluid tissue (e.g., wall of heart) to provide information or a mapping indicative of a position and/or orientation of the device in the cavity. Discrimination may be based on flow, or some other characteristic, for example electrical permittivity or force. The device may selectively ablate portions of the non-fluid tissue based on the information or mapping. The device may detect characteristics (e.g., electrical potentials) indicative of whether ablation was successful. The device may include a plurality of transducers, intravascularly guided in an unexpanded configuration and positioned proximate the non-fluid tissue in an expanded configuration. Expansion mechanism may include helical member(s) or inflatable member(s).Type: GrantFiled: January 26, 2022Date of Patent: September 6, 2022Assignee: KARDIUM INC.Inventors: Daniel Gelbart, Douglas Wayne Goertzen, Fernando Luis de Souza Lopes
-
Publication number: 20220260314Abstract: The invention uses a furnace retort made of silicon carbide to create a sintering furnace having no cold areas during debinding while having low heat losses during sintering. This is achieved by varying the wall thickness of the retort and taking advantage of the large increase in thermal conductivity of silicon carbide at lower temperatures. The special properties of silicon carbide also allow rapid cooling by exposing the outside of the retort directly to a high flow of cooling air.Type: ApplicationFiled: October 6, 2021Publication date: August 18, 2022Inventors: Daniel Gelbart, Thomas Robert Curran
-
Patent number: 11413091Abstract: A device positionable in a cavity of a bodily organ (e.g., a heart) may discriminate between fluid (e.g., blood) and non-fluid tissue (e.g., wall of heart) to provide information or a mapping indicative of a position and/or orientation of the device in the cavity. Discrimination may be based on flow, or some other characteristic, for example electrical permittivity or force. The device may selectively ablate portions of the non-fluid tissue based on the information or mapping. The device may detect characteristics (e.g., electrical potentials) indicative of whether ablation was successful. The device may include a plurality of transducers, intravascularly guided in an unexpanded configuration and positioned proximate the non-fluid tissue in an expanded configuration. Expansion mechanism may include helical member(s) or inflatable member(s).Type: GrantFiled: October 13, 2021Date of Patent: August 16, 2022Assignee: KARDIUM INC.Inventors: Daniel Gelbart, Douglas Wayne Goertzen, Fernando Luis de Souza Lopes
-
Patent number: 11399890Abstract: An intra-cardiac mapping system is based on locating the ports through which blood flows in or out the heart chambers. For many procedures, such as ablation to cure atrial fibrillation, locating the pulmonary veins and the mitral valve accurately allows to perform a Maze procedure. The location of the ports and valves is based on using the convective cooling effect of the blood flow. The mapping can be performed by a catheter-deployed expandable net or a scanning catheter. The same net or catheter can also perform the ablation procedure.Type: GrantFiled: April 11, 2019Date of Patent: August 2, 2022Assignee: KARDIUM INC.Inventors: Daniel Gelbart, Samuel Victor Lichtenstein
-
Patent number: 11389231Abstract: An intra-cardiac mapping system is based on locating the ports through which blood flows in or out the heart chambers. For many procedures, such as ablation to cure atrial fibrillation, locating the pulmonary veins and the mitral valve accurately allows to perform a Maze procedure. The location of the ports and valves is based on using the convective cooling effect of the blood flow. The mapping can be performed by a catheter-deployed expandable net or a scanning catheter. The same net or catheter can also perform the ablation procedure.Type: GrantFiled: March 29, 2019Date of Patent: July 19, 2022Assignee: KARDIUM INC.Inventors: Daniel Gelbart, Samuel Victor Lichtenstein
-
Patent number: 11389232Abstract: An intra-cardiac mapping system is based on locating the ports through which blood flows in or out the heart chambers. For many procedures, such as ablation to cure atrial fibrillation, locating the pulmonary veins and the mitral valve accurately allows to perform a Maze procedure. The location of the ports and valves is based on using the convective cooling effect of the blood flow. The mapping can be performed by a catheter-deployed expandable net or a scanning catheter. The same net or catheter can also perform the ablation procedure.Type: GrantFiled: April 11, 2019Date of Patent: July 19, 2022Assignee: KARDIUM INC.Inventors: Daniel Gelbart, Samuel Victor Lichtenstein
-
Patent number: 11331141Abstract: A device positionable in a cavity of a bodily organ (e.g., a heart) may discriminate between fluid (e.g., blood) and non-fluid tissue (e.g., wall of heart) to provide information or a mapping indicative of a position and/or orientation of the device in the cavity. Discrimination may be based on flow, or some other characteristic, for example electrical permittivity or force. The device may selectively ablate portions of the non-fluid tissue based on the information or mapping. The device may detect characteristics (e.g., electrical potentials) indicative of whether ablation was successful. The device may include a plurality of transducers, intravascularly guided in an unexpanded configuration and positioned proximate the non-fluid tissue in an expanded configuration. Expansion mechanism may include helical member(s) or inflatable member(s).Type: GrantFiled: October 21, 2019Date of Patent: May 17, 2022Assignee: KARDIUM INC.Inventors: Daniel Gelbart, Douglas Wayne Goertzen, Fernando Luis de Souza Lopes
-
Publication number: 20220142706Abstract: A device positionable in a cavity of a bodily organ (e.g., a heart) may discriminate between fluid (e.g., blood) and non-fluid tissue (e.g., wall of heart) to provide information or a mapping indicative of a position and/or orientation of the device in the cavity. Discrimination may be based on flow, or some other characteristic, for example electrical permittivity or force. The device may selectively ablate portions of the non-fluid tissue based on the information or mapping. The device may detect characteristics (e.g., electrical potentials) indicative of whether ablation was successful. The device may include a plurality of transducers, intravascularly guided in an unexpanded configuration and positioned proximate the non-fluid tissue in an expanded configuration. Expansion mechanism may include helical member(s) or inflatable member(s).Type: ApplicationFiled: January 26, 2022Publication date: May 12, 2022Inventors: Daniel GELBART, Douglas Wayne GOERTZEN, Fernando Luis de Souza LOPES
-
Patent number: 11304751Abstract: A device positionable in a cavity of a bodily organ (e.g., a heart) may discriminate between fluid (e.g., blood) and non-fluid tissue (e.g., wall of heart) to provide information or a mapping indicative of a position and/or orientation of the device in the cavity. Discrimination may be based on flow, or some other characteristic, for example electrical permittivity or force. The device may selectively ablate portions of the non-fluid tissue based on the information or mapping. The device may detect characteristics (e.g., electrical potentials) indicative of whether ablation was successful. The device may include a plurality of transducers, intravascularly guided in an unexpanded configuration and positioned proximate the non-fluid tissue in an expanded configuration. Expansion mechanism may include helical member(s) or inflatable member(s).Type: GrantFiled: October 24, 2019Date of Patent: April 19, 2022Assignee: KARDIUM INC.Inventors: Daniel Gelbart, Douglas Wayne Goertzen, Fernando Luis de Souza Lopes
-
Publication number: 20220047328Abstract: An intra-cardiac mapping system is based on locating the ports through which blood flows in or out the heart chambers. For many procedures, such as ablation to cure atrial fibrillation, locating the pulmonary veins and the mitral valve accurately allows to perform a Maze procedure. The location of the ports and valves is based on using the convective cooling effect of the blood flow. The mapping can be performed by a catheter-deployed expandable net or a scanning catheter. The same net or catheter can also perform the ablation procedure.Type: ApplicationFiled: October 28, 2021Publication date: February 17, 2022Inventors: Daniel GELBART, Samuel Victor LICHTENSTEIN
-
Publication number: 20220031391Abstract: A device positionable in a cavity of a bodily organ (e.g., a heart) may discriminate between fluid (e.g., blood) and non-fluid tissue (e.g., wall of heart) to provide information or a mapping indicative of a position and/or orientation of the device in the cavity. Discrimination may be based on flow, or some other characteristic, for example electrical permittivity or force. The device may selectively ablate portions of the non-fluid tissue based on the information or mapping. The device may detect characteristics (e.g., electrical potentials) indicative of whether ablation was successful. The device may include a plurality of transducers, intravascularly guided in an unexpanded configuration and positioned proximate the non-fluid tissue in an expanded configuration. Expansion mechanism may include helical member(s) or inflatable member(s).Type: ApplicationFiled: October 13, 2021Publication date: February 3, 2022Inventors: Daniel GELBART, Douglas Wayne GOERTZEN, Fernando Luis de Souza LOPES
-
Patent number: 11076913Abstract: A device positionable in a cavity of a bodily organ (e.g., a heart) may discriminate between fluid (e.g., blood) and non-fluid tissue (e.g., wall of heart) to provide information or a mapping indicative of a position and/or orientation of the device in the cavity. Discrimination may be based on flow, or some other characteristic, for example electrical permittivity or force. The device may selectively ablate portions of the non-fluid tissue based on the information or mapping. The device may detect characteristics (e.g., electrical potentials) indicative of whether ablation was successful. The device may include a plurality of transducers, intravascularly guided in an unexpanded configuration and positioned proximate the non-fluid tissue in an expanded configuration. Expansion mechanism may include helical member(s) or inflatable member(s).Type: GrantFiled: May 9, 2019Date of Patent: August 3, 2021Assignee: KARDIUM INC.Inventors: Daniel Gelbart, Douglas Wayne Goertzen, Fernando Luis de Souza Lopes